Large molecule facility doubles size of Australia’s top bioanalytical laboratory
As Australia’s premier bioanalytical and toxicology provider, Agilex Biolabs has played a pivotal role in accelerating biotech and pharma companies’ drug development programs. As it celebrates 25 years of bioanalytical excellence, the company appreciates and reflects on its first quarter-century. The company is committed to supporting the new and emerging areas of biotherapeutic modalities, including RNA vaccines, siRNA/miRNA clinical targets and gene therapy. Equipped with a full complement of top-of-the-line bioanalytical tools and a fast-growing team of experienced scientists, it is set to become Australia’s number one partner for trusted bioanalytical excellence.
Agilex Biolabs - Media Release (1)
You may also be interested in:
In association with:
